Articles published by Valo Health, Inc.

Valo Health and Montai Therapeutics Merge to Create Leading Drug Discovery Platform Powered by Human Evidence

November 11, 2026

From Valo Health, Inc.

Via Business Wire

Valo Health Appoints Chris Anagnostopoulos, PhD, as Chief Causal AI Officer

April 14, 2026

From Valo Health, Inc.

Via Business Wire

Valo Health Appoints Karin Conde-Knape, Ph.D., as Chief Scientific Officer

February 03, 2026

From Valo Health, Inc.

Via Business Wire

Valo Health Appoints Rita Kale as Chief Financial Officer

December 02, 2025

From Valo Health, Inc.

Via Business Wire

Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson’s Disease and Related Disorders

November 20, 2025

From Valo Health, Inc.

Via Business Wire

Valo Health Awarded Grant from The Michael J. Fox Foundation to Advance Parkinson’s Disease Research

September 09, 2025

From Valo Health, Inc.

Via Business Wire

Valo Health Appoints Accomplished Executive Peggy Dalicandro as Vice President, Head of Human Resources

March 20, 2025

From Valo Health, Inc.

Via Business Wire

Valo Health and nference Announce Long-term Partnership to Accelerate Human-Centric Drug Discovery and Development

March 18, 2025

From Valo Health, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Articles published by Valo Health, Inc.

Starting at /week.